India Medical Devices Regulations

Regulatory requirements for medical devices in India

Medical Device Rules India

India Medical Device Regulations

The India Medical Device Regulations operate under the Medical Device Rules 2017 and the Medical Device (Amendment) Rules 2020. These regulations establish the guidelines for the approval, registration, and administration of medical devices and in-vitro diagnostic devices (IVDs) in India.

The Central Drugs Standard Control Organization (CDSCO) is the central regulatory authority for medical devices and IVDs in India. Governed by the Ministry of Health and Family Welfare, the CDSCO ensures compliance with these regulations to maintain medical products' quality, safety, and efficacy.

The Drugs and Cosmetics Act 1940 provides the legal foundation for the regulatory framework for medical devices and IVDs. These regulations and governing bodies streamline the approval process, ensuring that all medical devices and IVDs meet stringent safety and performance standards.

GO-TO-MARKET STRATEGY AND REGISTRATION SUPPORT

Do you need assistance with your strategy with the India Medical Device Regulations?  

 

Contact us

https://www.qservegroup.com/write/Afbeeldingen1/05. Market Access/India Medical Device Regulations.jpg?preset=content

Medical Device Classification in India

India Medical Device Regulations

India's medical device classification system follows a risk-based approach, aligning with the EU and FDA systems in the US. Medical devices are categorized into four classes based on their risk levels:

  • Class A: Low risk
  • Class B: Low-moderate risk
  • Class C: Moderate-high risk
  • Class D: High risk

The Central Licensing Authority (CLA) is responsible for classifying medical devices under the India Medical Device Regulations, governed by the Central Drugs Standard Control Organization (CDSCO). The CDSCO specifies which products are classified as medical devices requiring registration and provides a comprehensive list of device categories.

Manufacturers can self-declare the products of Class A devices. These devices must be registered in the Indian online system, providing details such as:

  • Manufacturer's name
  • Address
  • Product generic name
  • Brand name

Similarly, importers must complete the online registration to comply with regulatory requirements.

This streamlined classification and registration process ensures that medical devices meet India's regulatory standards while maintaining safety and quality for end users.


Representation for foreign manufacturers

Appoint an Indian Authorized Agent

Companies must obtain a manufacturing import permit approved by the Central Drugs Standard Control Organization (CDSCO) to distribute medical devices in India legally. The Indian Authorized Agent (IAA) applies for this permit through the online SUGAM portal.

If a company does not have a physical presence in India, it must appoint a local Indian Authorized Agent (IAA). The IAA plays a critical role in ensuring compliance with Indian regulations. Multiple authorized agents can register the same product, offering flexibility for foreign manufacturers. The IAA can be:

  • A foreign company’s local office in India
  • An independent agency
  • An appointed natural person

By appointing an IAA, companies ensure a streamlined registration process and compliance with Indian medical device regulations.

Global regulatory strategy

With a population of approximately 1.4 billion, India relies heavily on imports for advanced medical devices, sourcing 90% of sophisticated medical devices from international markets. The Indian government continues to invest significantly in healthcare infrastructure and the medical device industry, creating a thriving potential market for Medical Device and In Vitro Diagnostic (IVD) manufacturers.

Qserve helps you navigate the complexities of India Medical Device Regulations by aligning your global regulatory strategy with the unique requirements of the Indian market.

 

Free introductory call

Medical Device Registration and IVDs

Qserve’s regulatory consulting specialists support your market access efforts in the Indian medical device and IVD market. Leveraging your current compliance status, we conduct a comprehensive gap analysis to identify overlaps and missing elements, helping you complete your technical documentation efficiently and effectively.

Our expertise ensures you meet the essential regulatory requirements for medical device registration and IVD compliance in India. With Qserve, you gain access to industry-leading knowledge and guidance.

 

Contact us

Qserve services for India

Qserve provides comprehensive support for companies entering the Indian medical device and IVD market. Our expert team ensures seamless regulatory compliance and market access with tailored solutions, including:

  • Global Regulatory Strategy
  • Registration support in India
  • Online registration in India
  • Indian Authorized Agent support
  • CDSCO license requirements support
  • Translation labels and IFUs based on requirements




Services

Registration routes in India

Medical approval process in India

The registration of medical devices in India has become mandatory, effective 1 October 2023. The registration applies to all new Class A (measuring or sterile), Class B, Class C, and Class D devices. Considering that registration before the application date of 1 October 2023 was voluntary, CDSCO allowed for an enforced transition until 1 October 2023.

Manufacturers are expected to provide comprehensive technical documentation, including clinical evidence, on their products. By utilizing similar technical documentation, manufacturers can benefit from their existing market approvals. However, compared to other countries, CDSCO India Medical Device Regulations focuses on predicate devices on the market, which will benefit the registration process.

Abridged routes to the Indian Market

Two types of registration pathways 

Option 1: Predicate device and approval in a GHTF* country.
India recognizes certain countries’ regulatory approvals to decrease overall review timelines and complete a simplified assessment process. The FDA follows a faster assessment pathway for devices approved under the scope of a CE mark than those without. Conformity to ISO 13485:2016 is a recognized quality management system in India. 

Option 2: Predicate device and no approval in a GHTF country.
The Special Expert Committee (SEC) will execute the technical assessment process. The review lead times depend on the type of device and associated risk class. The device falls under an ‘Investigational Medical Device.’ The SEC focuses on the requirements for clinical evidence and the performance of the devices remaining unchanged in the Indian population.

Expand your knowledge

On-demand webinar

The free webinar series on Medical Device Registration will cover interesting topics on how to enter the Asia-Pacific (APAC) and Latin-American (LATAM) markets and how to meet regulatory compliance. Learn more about the regulatory framework in India, Australia, New Zealand, and Malaysia, presented by our regulatory affairs associates.

Webinar

Regulatory timelines and fees

How long does it take to enter
the Indian medical device market? 

Class A (non-sterile and non-measuring) devices are immediately approved. For higher-risk classes (Notified devices), depending on the approach, the turnaround time is 6-9 months* or 18+ months (in case of no predicate device, clinical trials are required for approval). 

Explore your journey

Understanding the regulations

Making informed choices

Understanding the pros and cons of the various pathways for market access in India is essential to making informed choices. To understand the most feasible and cost effective approach to enter the Indian market, Qserve can help you in determining your regulatory roadmap. 


Free introductory call